期刊文献+

The Relationship between Serum VEGF Expression and PET/CT Images in TNM-staging of Lung Carcinoma

The Relationship between Serum VEGF Expression and PET/CT Images in TNM-staging of Lung Carcinoma
下载PDF
导出
摘要 OBJECTIVE To analyze the relationship between the characteristics of PET/CT images for lung carcinoma(LC)TNM staging and the expression of serum VEGF protein. METHODS PET/CT examinations were performed before treatment of 53 patients with LC.The expression of serum VEGF protein was examined using a quantitative sandwich enzyme-linked immunosorbent assay(ELISA R and D system).The relationship was analyzed between PET/CT images for LC T-staging and metastasis(lymph nodes and distance)and serum VEGF expression. RESULTS Based on PET/CT images for LC T-staging,11 cases were staged as T1,9 as T2,18 as T3 and 15 as T4.Mediastinal nodal metastases were found in 22 patients,and distance metastasis in 9.The serum VEGF level in the LC patients was(378.02±180.79)ng/L,showing that there was a significant difference between the patients and healthy subjects(P<0.05). There was no significant difference in the level of serum VEGF between different low T-staged(T1,T2)patients.However,the level of serum VEGF was significantly different between the low T-staged(T1,T2)and high T-staged (T3,T4)patients(P<0.05).The level of the serum VEGF protein in the patients with mediastinal nodal metastasis was(561.50±104.55)ng/L,and indicating that there was a statistical significance(t=12.21,P<0.05)compared to those in the non-metastatic group.The level of serum VEGF in the patients with distance metastasis was(614.11±158.81)ng/L,demonstrating that there was a significant difference(t=5.30,P<0.05)compared to those in the nondistant metastatic group. CONCLUSION ① There is a high level of serum VEGF expression in LC patients.②There is a correlation between metastases(lymph nodes and distance)and the level of serum VEGF. ③ With an upgrade of the TNM-stage,the level of serum VEGF protein is elevated. OBJECTIVE To analyze the relationship between the characteristics of PET/CT images for lung carcinoma (LC) TNM staging and the expression of serum VEGF protein. METHODS PET/CT examinations were performed before treatment of 53 patients with LC. The expression of serum VEGF protein was examined using a quantitative sandwich enzyme-linked immunosorbent assay (ELISA R and D system). The relationship was analyzed between PET/CT images for LC T-staging and metastasis (lymph nodes and distance) and serum VEGF expression. RESULTS Based on PET/CT images for LC T-staging, 11 cases were staged as T1, 9 as T2, 18 as T3 and 15 as T4. Mediastinal nodal metastases were found in 22 patients, and distance metastasis in 9. The serum VEGF level in the LC patients was (378.02±180.79) ng/L, showing that there was a significant difference between the patients and healthy subjects (P〈0.05). There was no significant difference in the level of serum VEGF between different low T-staged (T1, T2) patients. However, the level of serum VEGF was significantly different between the low T-staged (T1, T2) and high T-staged (T3, T4) patients (P〈0.05). The level of the serum VEGF protein in the patients with mediastinal nodal metastasis was (561.50±104.55) ng/L, and indicating that there was a statistical significance (t=12.21, P〈0.05) compared to those in the non-metastatic group. The level of serum VEGF in the patients with distance metastasis was (614.11±158.81) ng/L, demonstrating that there was a significant difference (t=5.30, P〈0.05) compared to those in the non- distant metastatic group. CONCLUSION ①There is a high level of serum VEGF expression in LC patients.②There is a correlation between metastases (lymph nodes and distance) and the level of serum VEGF.③With an upgrade of the TNM- stage, the level of serum VEGF protein is elevated.
出处 《Chinese Journal of Clinical Oncology》 CSCD 2007年第5期313-317,共5页 中国肿瘤临床(英文版)
基金 a grant from theScientic Fund of the Public Health Bureau ofHunan Province(No.B2005139).
  • 相关文献

参考文献2

二级参考文献11

  • 1Coleman RE. PET in lung cancer. J Nucl Med, 1999, 40: 814-820.
  • 2Dominique D. Oncological application of FDG PET imaging. J Nucl Med,1999, 40: 1706-1715.
  • 3Antoch G, Stattaus J, Nemat AT, et al. Non-small-cell lung cancer: dual-modality PET/CT in preoperative staging. Radiology, 2003, 229: 526-533.
  • 4Lardinois D, Weder W, Hany TF, et al. Staging of non-small-cell lung cancer with integrated positron emission tomography and computed tomography. New Engl J Med, 2003, 348: 2500-2507.
  • 5Ciemik IF, Dizendorf E, Baumert BG, et al. Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT):a feasibility study. Int J Radiat Oncol Biol Phys, 2003, 57: 853-863.
  • 6MATTHIES A, HICKESON M, CUCHIARA A, et al. Dual time point ^18F-FDG-PET for the evaluation of pulmonary nodules [J]. J Nucl Med, 2002,43(7):871-875.
  • 7MANOLA J, ATKINS M, IBRAHIM J, et al. Prognostic factors in metastatic melanoma pooled analysis of eastern cooperative oncology group trials [J]. J Clin Oncol, 2000,18(22) : 3782-3793.
  • 8LINKE R, SCHROEDER M, HELMBERGER T, et al.Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis [J]. Neurology, 2004,63(2) : 282-286.
  • 9GALLOWITSCH H J, KRESNIK E, GASSER J, et al. F-18 fluorodeoxyglucose positron-emission tomography in the diagnosis of tumor recurrence and metastases in the follow-up of patients with breast carcinoma: a comparison to conventional imaging [ J ]. Invest Radiol, 2003,38 (5) : 250-256.
  • 10JOHNSON G R, ZHUANG H M, KHAN J, et al. Roles of positron emission tomography with fluorine-18-deoxyglucose in the detection of local r~urrent and distant metastatic sarcoma[J]. Clin Nucl Med, 2003,28(10) :815-820.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部